Homocysteine, iron and cardiovascular disease: A hypothesis

Nutrients

Volumn 7, Issue 2, 2015, Pages 1108-1118

  Baggott, Joseph E ^a   Tamura, Tsunenobu ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cardiovascular disease; Homocysteine; Iron; Methionine; Thioether

Indexed keywords

ANTICOAGULANT AGENT; CYSTATHIONINE; FERRITIN; HOMOCYSTEINE; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; S ADENOSYLHOMOCYSTEINE; VITAMIN B GROUP; BIOLOGICAL MARKER; FOLIC ACID; FREE RADICAL; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VITAMIN B COMPLEX;

BLOOD SAMPLING; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; OXIDATION; PH; REVIEW; BLOOD; CARDIOVASCULAR DISEASES; DIET SUPPLEMENTATION; DIET THERAPY; METABOLISM; RISK FACTOR;

BIOMARKERS; CARDIOVASCULAR DISEASES; CYSTATHIONINE; DIETARY SUPPLEMENTS; FOLIC ACID; FREE RADICALS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; IRON; LIPOPROTEINS, LDL; METHIONINE; RISK FACTORS; S-ADENOSYLHOMOCYSTEINE; VITAMIN B COMPLEX;

EID: 84922545551     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7021108     Document Type: Review

References (43)

1. Finkelstein, J.D. Methionine metabolism in mammals. J. Nutr. Biochem. 1990, 1, 228-237.
2. McCully, K.S. Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: A key case revisited. Nutr. Rev. 1992, 50, 7-12.
3. Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.; Graham, I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 1991, 324, 1149-1155.
4. Refsum, H.; Ueland, P.M.; Nygård, O.; Vollset, S.E. Homocysteine and cardiovascular disease. Ann. Rev. Med. 1998, 49, 31-62.
5. Yang, H.-T.; Lee, M.; Hong, K.-S.; Ovbiagele, B.; Saver, J.L. Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Eur. J. Int. Med. 2012, 23, 745-754.
6. Holvoet, P.; Collen, D. Oxidized lipoproteins in atheroscerosis and thrombosis. FASEB J. 1994, 8, 1279-1284.
7. Aisen, P.; Cohen, G.; Kang, J.O. Iron toxicosis. Int. Rev. Exp. Pathol. 1990, 31, 1-46.
8. Sullivan, J.L. Iron and the sex difference in heart disease risk. Lancet 1981, 1, 1293-1294.
9. Muñoz-Bravo, C.; Gutiérrez-Bedmar, M.; Gómez-Aracena, J.; García-Rodoríguez, A.; Navajas, J.F.-C. Iron: Protector or risk factor for cardiovascular disease? Still controversial. Nutrients 2013, 5, 2384-2404.
10. Lapice, E.; Masulli, M.; Vaccaro, O. Iron deficiency and cardiovascular disease: An updated review of the evidence. Curr. Atheroscler. Rep. 2013, 15, 358, doi:10.1007/s11883-013-0358-0.
11. Hsu, H.-S.; Li, C.-I.; Liu, C.-S. Lin, C.-C.; Haung, K.-C.; Li, T.-C.; Haung, H.-Y.; Lin, W.-Y. Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities. Nutrition 2013, 29, 737-743.
12. Bacon, B.R.; Tavill, A.S. Role of the liver in normal iron metabolism. Sem. Liver Dis. 1984, 4, 181-192.
13. Lamb, D.J.; Leake, D.S. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein. FEBS Lett. 1994, 352, 15-18.
14. Bothwell, T.H.; Charlton, R.W.; Motulsky, A.G. Hemochromatosis. In The Metabolic and Molecular Basis of Inherited Disease, 7th ed.; Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Eds.; McGraw-Hill: New York, NY, USA, 1995; pp. 2237-2269.
15. Daher, R.; van Lente, F. Relationship of increased homocysteine with copper, iron, and zinc concentrations in serum. Irish J. Med. Sci. 1995, 164 (15), 21.
16. Zheng, H.; Huang, X.; Zhang, Q.; Katz, S.D. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int. 2006, 69, 679-684.
17. Facchini, F.S.; Saylor, K.L. Effect of iron depletion on cardiovascular risk factors. Studies in carbohydrate-intolerant patients. Ann. N. Y. Acad. Sci. 2002, 967, 342-351.
18. Stabler, S.P.; Marcell, P.D.; Podell, E.R.; Allen, R.H. Quantitation of total homocysteine, total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal. Biochem. 1987, 162, 185-196.
19. Ubbink, J.B.; Vermaak, W.J.H.; van der Merwe, A.; Becker, P.J. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin. Chim. Acta 1992, 207, 119-128.
20. Andersson, A.; Isaksson, A.; Hultberg, B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin. Chem. 1992, 38, 1311-1315.
21. Willems, H.P.J.; Bos, G.M.J.; Gerrits, W.B.J.; den Heijer, M.; Vloet, S.; Blom, H.J. Acidic citrate stabilizes blood samples for assay of total homocysteine. Clin. Chem. 1998, 44, 342-345.
22. Hughes, M.P.; Carlson, T.H.; McLaughlin, M.K.; Bankson, D.D. Addition of sodium fluoride to whole blood does not stabilize plasma homocysteine but produces dilution effects on plasma constituents and hematocrit. Clin. Chem. 1998, 44, 2204-2206.
23. Salazar, J.-F.; Herbeth, B.; Siest, G.; Leroy, P. Stability of blood homocysteine and other thiols: EDTA or acidic citrate? Clin. Chem. 1999, 45, 2016-2019.
24. Palmer-Toy, D.E.; Szczepiorkowski, Z.M.; Shih, V.; van Cott, E.M. Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrate whole blood. Clin. Chem. 2001, 47, 1704-1707.
25. Calişkan, S.; Kuralay, F.; Önvural, B. Effect of anticoagulants on plasma homocysteine determination. Clin. Chim. Acta 2001, 309, 53-56.
26. Duarte, N.L.; Wang, X.L.; Wilken, D.E.L. Effects of anticoagulant and time of plasma separation on measurement of homocysteine. Clin. Chem. 2002, 48, 665-668.
27. Scheidhauer, R.; Guessregen, B.; Hohl, A.; Arndt, T. Effects of prolonged ambient storage of sodium fluoride/heparin specimens on plasma homocysteine. Clin. Chem. 2005, 51, 1564-1565.
28. Hübner, U.; Schorr, H.; Eckert, R.; Geisel, J.; Herrmann, W. Stability of plasma homocysteine, S-adenosylmethionine, and S-adenosylhomocysteine in EDTA, acidic citrate, and PrimavetteTM collection tubes. Clin. Chem. 2007, 53, 2217-2218.
29. Tamura, T.; Baggott, J.E. In vitro formation of homocysteine in whole blood in the presence of anticoagulants. Clin. Chem. 2008, 54, 1402-1403.
30. Martín, J.; Gilbert, M.J.; Vila, M.; Pintos, C.; Obrador, A.; Malo, O. Stabilization of blood homocysteine in an epidemiological setting. Eur. J. Cancer Prev. 2001, 10, 473-476.
31. Hill, D.M.; Johnson, L.J.; Burns, P.J.; Neale, A.M.; Harmening, D.M.; Kenney, A.C. Effects of temperature on stability of blood homocysteine in collection tubes containing 3-deazaadenosine. Clin. Chem. 2002, 48, 2017-2022.
32. Baggott, J.E.; Tamura, T. Iron-dependent formation of homocysteine from methionine and other thioethers. Eur. J. Clin. Nutr. 2007, 61, 1359-1363.
33. Nalini, S.; Ramakrishna, B.S.; Mohanty, A.; Balasubramanian, K.A. Hydroxyl radical formation in human gastric juice. J. Gastroenterol. Hepatol. 1992, 7, 497-501.
34. Nakivell, B.J.; Tay, Y.C.; Boadle, R.A.; Harris, D.C.H. Lysosomal iron accumulation in diabetic nephropathy. Ren. Fail. 1994, 16, 367-381.
35. Mattioli, A.V.; Benetti, L.; Zennaro, M.; Bertoncelli, P.; Mattioli, G. Acute myocardial infarction in young patients: Nutritional status and biochemical factors. Int. J. Cardiol. 2005, 101, 185-190.
36. Schiepers, O.J.G.; van Boxtel, M.P.J.; de Groot, R.H.M.; Jolles, J.; de Kort, W.L.A.M.; Swinkels, D.W.; Kok, F.J.; Verhoef, P.; Durga, J. Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: Results from the FACIT study. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65, 1312-1321.
37. Baggott, J.E.; Tamura, T. Serum iron parameters and plasma total homocysteine concentrations. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66A, 656, doi:10.1093/gerona/glr018.
38. Schiepers, O.J.G.; Durga, J. Response to Baggott and Tamura: “Serum iron parameters and plasma total homocysteine concentrations.” J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66A, 657-658.
39. Lioupis, C.; Barbatis, C.; Drougou, A.; Koliaraki, V.; Mamalaki, A.; Klonaris, C.; Georgopoulos, S.; Andrikopoulos, V.; Bastounis, E. Association of heptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques. Atherosclerosis 2011, 216, 131-138.
40. Peña-Duque, M.A.; Baños-González, M.A.; Valente-Acosta, B.; Rogoríguez-Lobato L.G.; Martínes-Ríos, M.A.; Cardoso-Saldaña, G.; Barragán-García, R.; Herrera-Alarcón, V.; Linares-López, C.; Delgado-Granados, H., et al. Homocysteine is related to aortic mineralization in patients with ischemic heart disease. J. Atheroscl. Thrombo. 2012, 19, 292-297.
41. Pinková, K.; Chrastinová, L.; Suttnar, J.; Štikanová, J.; Kotlín, R.; Čermák, J.; Dyr, J.E. Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload. Oxid. Med. Cell. Long. 2014, 2014, doi:10.1155/2014/416028.
42. Greenough, M.A.; Camakaris, J.; Bush, A.I. Metal dyshomeostasis and oxidative stress in Alzheimer’s disease. Neurochem. Int. 2013, 62, 540-555.
43. Brattstrӧm, L.; Wilcken, D.E.L. Homocysteine and cardiovascular disease: Cause or effect? Am. J. Clin. Nutr. 2000, 72, 315-323.